Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Acid-suppressant medications in infants with bronchiolitis raises later allergy risk

Key clinical point: Use of acid-suppressant drugs in infants for severe bronchiolitis may increase their risk of developing wheeze at age 3 years.

Major finding: Of the infants who received acid-suppressant medications, 43% went on to develop recurrent wheeze, compared with 29% who were not exposed.

Study details: A cohort study of 921 infants who were hospitalized for severe bronchiolitis between 2011 and 2014.

Disclosures: Dr. Robinson reported no relevant financial disclosures.

Citation:

Robinson L. AAAAI 2020, Abstract L1.